Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NervGen Pharma Corp V.NGEN

Alternate Symbol(s):  NGENF

NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in discovery, development and commercialization of pharmaceutical products for the treatment of nervous system damage due to injury or disease. The Company is advancing its lead compound, NVG-291, for the treatment of spinal cord injury (SCI), Alzheimer’s disease (AD) and multiple sclerosis (MS). Its NVG-291 is a therapeutic peptide, which is a mimetic of the intracellular domain of protein tyrosine phosphatase, a cell surface receptor known to interact with chondroitin sulfate proteoglycans (CSPGs) and to be involved in the regulation of neuroplasticity and central nervous system repair. The Company has two wholly owned subsidiaries, including NervGen US Inc. and NervGen Australia Pty Ltd.


TSXV:NGEN - Post by User

Post by deepoil0808on Mar 21, 2024 7:34pm
293 Views
Post# 35946086

Bought deal RAISES questions. Why now?

Bought deal RAISES questions. Why now?Stock has plunged from +/- $ 3.80 to $ 2.48 today, a big drop.

One insider sold +/- 30% of their holdings at $ 3

Market place published an article PROMOTING the company while a bought deal of $ 20 million is being done. 

I do not like what I see.   

So some hard questions.

- why raise money now if results are going to be great?   Seems to be counter productive.    

- why does insider sell 33% of their holdings if results are going to be great?

- anytime I see PROMOTION with bought deals, it is never a good sign....it gives me the impression of sales pitching someone as to how great they are and to give them money.

I do not have a position and will wait for trial results.   If results are great, it will not matter at what price you buy cause it will only go higher the next day.

However if results are bad, then it is penny status for good. 

For me, it is not worth the risk. 

My personal opinion, 

Good Luck, 



<< Previous
Bullboard Posts
Next >>